))
June 28, 2025 - Life Sciences Weekly Recap
Manage episode 491393555 series 3663442
Content provided by Matthew Davison. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matthew Davison or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Life Sciences Weekly - Episode 7
Recorded: June 28, 2025
In Episode 7 of Life Sciences Weekly, host Matt Davison delivers a comprehensive roundup of the week’s biggest developments in biotech, pharma, and medtech as of June 28, 2025. Tune in for a detailed market snapshot—including ETF performance and sector drivers—before diving into a packed slate of FDA approvals and regulatory actions, from Stryker’s new ankle system and the first sutureless nerve repair device to expanded Alzheimer’s imaging labels and major cancer therapy advances. The episode covers key funding rounds, including CalmWave, ForSight Robotics, and a $2B commitment to Revolution Medicines, alongside major M&A moves like Synthego’s sale, Illumina’s SomaLogic deal, and Gentell’s acquisition of Casex. In the Industry Spotlight, Matt breaks down the FDA’s removal of REMS requirements for most CAR-T cell therapies, a move set to double patient access nationwide. Whether you’re an industry insider or just curious about the future of healthcare, this episode has you covered with in-depth analysis.
With your Life Sciences Industry Guide, Matt Davison
7 episodes
Share
